Billion-dollar private venture capital rounds are apparently now a "thing." Roivant sealed the deal on Wednesday, following a multi-year trend towards bigger investment rounds in the life sciences.
The unpredictable president-elect has made industry forecasting a much tougher job. But the show must go on. Here are some highlights from Evaluate Pharma's new 2017 biopharma report; the winners, the losers and more.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Biotech venture rounds favored "the lucky few" in 2015, as more cash was poured into a smaller number of upper echelon life sciences companies.
A new medtech job growth report from EP Vantage suggests the level of consolidation and spinout activity we saw in 2014 could be repeated this year.
Looks like employment’s steady globally in the medical device sector, despite the doom-and-gloom provocations from those stateside who have been concerned about the U.S. medical device excise tax killing medtech jobs. Most medical manufacturers actually increased their employee count for the year, according to a new report from EP Vantage. Of the top 15 device makers, only […]